Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. (2013)
Attributed to:
Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0076907
PubMed Identifier: 24130809
Publication URI: http://europepmc.org/abstract/MED/24130809
Type: Journal Article/Review
Volume: 8
Parent Publication: PloS one
Issue: 10
ISSN: 1932-6203